Search Results for 'placebo hiv'

placebo hiv published presentations and documents on DocSlides.

HIV Prevention England Conference
HIV Prevention England Conference
by felicity
18 February 2020. -. A two-stage randomised phase ...
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
by shmuel184
iPrEx. Trial . Substudy. TDF-FTC versus Placebo a...
Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of
Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of
by briana-ranney
B. Wamuti. , J. Odoyo, B. Rono, C. Cohen, E. Buku...
The Bangkok Tenofovir Study
The Bangkok Tenofovir Study
by marina-yarberry
An HIV pre-exposure prophylaxis trial in Thailand...
Progress in the HIV Vaccine Field
Progress in the HIV Vaccine Field
by eatsui
Larry Corey, MD. Principal Investigator, NIAID sup...
Pre-exposure Prophylaxis for HIV Prevention
Pre-exposure Prophylaxis for HIV Prevention
by pamella-moone
Efficacy and the importance of adherence. Joanne ...
CROI 2015: HIV Prevention Updates
CROI 2015: HIV Prevention Updates
by pamella-moone
Ruanne V Barnabas, . MBChB. . Dphil. Global Heal...
Michael S.  Saag , MD  Eric S.
Michael S. Saag , MD Eric S.
by pamella-moone
Daar. , MD. Antiretroviral Therapy:. A Case-Based...
ART as prevention: PEP &
ART as prevention: PEP &
by phoebe-click
PrEP. Dr. Laura Waters. HIV/GU Medicine. Brighto...
Long Acting Injectable Agents for HIV Prevention
Long Acting Injectable Agents for HIV Prevention
by giovanna-bartolotta
Nyaradzo M Mgodi (. MBChB. , . MMed. ). On behalf...
Eric S.  Daar , MD Professor of Medicine
Eric S. Daar , MD Professor of Medicine
by faustina-dinatale
David Geffen School of Medicine. at University of...
ART for Prevention… What Happens Next?
ART for Prevention… What Happens Next?
by briana-ranney
Myron S. Cohen, MD. Yeargan-Bate Eminent Professo...
What’s Next – and When:
What’s Next – and When:
by sherrill-nordquist
An Update on Injectable . P. revention. Alex R Ri...
Towards ending  the AIDS Epidemic:  Progress and Evidence
Towards ending the AIDS Epidemic: Progress and Evidence
by shoulderheinz
Willard . Tinago. , . PhD. HIV . Molecular Researc...
A Vaginal Ring Containing
A Vaginal Ring Containing
by gelbero
Dapivirine. for HIV-1 PrEP. . Ring. A Vaginal Ri...
“Weighing” in on GLP-1 Receptor Agonists
“Weighing” in on GLP-1 Receptor Agonists
by priscilla
for People With HIV. Suman Srinivasa, MD, MS. Mass...
PROUD: Results and participant experiences
PROUD: Results and participant experiences
by catherine
Presented by . Mitzy. . Gafos. , behalf of the P...
Lynn Morris  Deputy Vice-Chancellor, Research and
Lynn Morris Deputy Vice-Chancellor, Research and
by helene
Innovation. University of the Witwatersrand, Johan...
Long-acting Capsid Inhibitor Effective as
Long-acting Capsid Inhibitor Effective as
by CottonTails
PrEP. Against Vaginal SHIV Transmission in Macaqu...
Safety and acceptability trial of the dapivirine vaginal ring in U.S. adolescents
Safety and acceptability trial of the dapivirine vaginal ring in U.S. adolescents
by ximena
K. Bunge. , L. Levy, D. Szydlo, J. Zhang, A. Gaur,...
HVTN 702  Confidential – Do Not Distribute
HVTN 702 Confidential – Do Not Distribute
by quinn
HVTN 702 Protocol Team. Confidential – Do Not Di...
Innovations in HIV Prevention Research
Innovations in HIV Prevention Research
by numeroenergy
:. Novel adherence and diagnostic technologies. Cr...
 Application of the Data:
Application of the Data:
by giovanna-bartolotta
Cardiometabolic Disease Is an Epidemic. Clinical ...
Statistical Design and Analysis for Immune Correlates Asses
Statistical Design and Analysis for Immune Correlates Asses
by myesha-ticknor
Basic Concepts and RV144 Illustration. Yunda Huan...